Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Awasthi

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
Frontiers in Immunology|April 19, 2021
Gefitinib Results in Robust Host-Directed Immunity Against <i>Salmonella</i> Infection Through Proteo-Metabolomic ReprogrammingSrikanth Sadhu, Zaigham Abbas Rizvi, Ramendra Pati Pandey, et al.
IJID Regions|November 17, 2025
Immunogenicity and safety of Biological E's CORBEVAX™ vaccine as a heterologous booster dose in adult volunteers previously vaccinated with two doses of either COVISHIELD™ or COVAXIN: A prospective double-blind randomized phase III clinical studySubhash Thuluva, Vikram Paradkar, SubbaReddy Gunneri, et al.
Cureus|December 18, 2023
Cell-Mediated Immunity (CMI) for SARS-CoV-2 Infection Among the General Population of North India: A Cross-Sectional Analysis From a Sub-sample of a Large Sero-Epidemiological StudyPuneet Misra, Pramod K Garg, Amit Awasthi, et al.
NPJ Biofilms and Microbiomes|March 14, 2025
Gut commensals-derived succinate impels colonic inflammation in ulcerative colitisRajdeep Dalal, Srikanth Sadhu, Aashima Batra, et al.
Journal of Medical Virology|August 22, 2024
Understanding the landscape of the SARS-CoV-2-specific T cells post-omicron surgeAkshay Binayke, Aymaan Zaheer, Siddhesh Vishwakarma, et al.
ACS Nano|August 1, 2025
Lumazine Synthase Nanoparticles as a Versatile Platform for Multivalent Antigen Presentation and Cross-Protective Coronavirus VaccinesJeswin Joseph, Kavitha Modenkattil Sethumadhavan, Priyanca Ahlawat, et al.
Frontiers in Molecular Biosciences|April 3, 2023
G4-binding drugs, chlorpromazine and prochlorperazine, repurposed against COVID-19 infection in hamstersShuvra Shekhar Roy, Shalu Sharma, Zaigham Abbas Rizvi, et al.
ACS Central Science|October 30, 2019
A Localized Chimeric Hydrogel Therapy Combats Tumor Progression through Alteration of Sphingolipid MetabolismSanjay Pal, Nihal Medatwal, Sandeep Kumar, et al.
Elife|January 11, 2022
Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infectionZaigham Abbas Rizvi, Rajdeep Dalal, Srikanth Sadhu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 2, 2021
Nrf2 through Aryl Hydrocarbon Receptor Regulates IL-22 Response in CD4<sup>+</sup> T CellsXun Lin, Suzanne Tawch, Hoi Tong Wong, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Frontiers in Immunology|April 19, 2021
Gefitinib Results in Robust Host-Directed Immunity Against <i>Salmonella</i> Infection Through Proteo-Metabolomic ReprogrammingSrikanth Sadhu, Zaigham Abbas Rizvi, Ramendra Pati Pandey, et al.
IJID Regions|November 17, 2025
Immunogenicity and safety of Biological E's CORBEVAX™ vaccine as a heterologous booster dose in adult volunteers previously vaccinated with two doses of either COVISHIELD™ or COVAXIN: A prospective double-blind randomized phase III clinical studySubhash Thuluva, Vikram Paradkar, SubbaReddy Gunneri, et al.
Cureus|December 18, 2023
Cell-Mediated Immunity (CMI) for SARS-CoV-2 Infection Among the General Population of North India: A Cross-Sectional Analysis From a Sub-sample of a Large Sero-Epidemiological StudyPuneet Misra, Pramod K Garg, Amit Awasthi, et al.
NPJ Biofilms and Microbiomes|March 14, 2025
Gut commensals-derived succinate impels colonic inflammation in ulcerative colitisRajdeep Dalal, Srikanth Sadhu, Aashima Batra, et al.
Journal of Medical Virology|August 22, 2024
Understanding the landscape of the SARS-CoV-2-specific T cells post-omicron surgeAkshay Binayke, Aymaan Zaheer, Siddhesh Vishwakarma, et al.
ACS Nano|August 1, 2025
Lumazine Synthase Nanoparticles as a Versatile Platform for Multivalent Antigen Presentation and Cross-Protective Coronavirus VaccinesJeswin Joseph, Kavitha Modenkattil Sethumadhavan, Priyanca Ahlawat, et al.
Frontiers in Molecular Biosciences|April 3, 2023
G4-binding drugs, chlorpromazine and prochlorperazine, repurposed against COVID-19 infection in hamstersShuvra Shekhar Roy, Shalu Sharma, Zaigham Abbas Rizvi, et al.
ACS Central Science|October 30, 2019
A Localized Chimeric Hydrogel Therapy Combats Tumor Progression through Alteration of Sphingolipid MetabolismSanjay Pal, Nihal Medatwal, Sandeep Kumar, et al.
Elife|January 11, 2022
Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infectionZaigham Abbas Rizvi, Rajdeep Dalal, Srikanth Sadhu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 2, 2021
Nrf2 through Aryl Hydrocarbon Receptor Regulates IL-22 Response in CD4<sup>+</sup> T CellsXun Lin, Suzanne Tawch, Hoi Tong Wong, et al.
Pageof 13